hSNF5/INI1 acts to repress Aurora A expression; as such, loss of INI1/hSNF5 in rhabdoid tumors leads to aberrant overexpression of Aurora A which is required for tumor survival in non-clinical cancer models (47). The gene discussed is SMARCB1; the disease is neoplasm.